Skip to main content
. 2018 Jun 1;12(7):707–716. doi: 10.2217/bmm-2017-0373

Table 3. . Selected subjects with high DLL1 values and without microbiologic evidence of tuberculosis meningitis or Cryptococcus.

Clinical meningitis diagnosis DLL1 pg/ml VDBP μg/ml Fetuin μg/ml CSF WBC cells/μl CSF protein mg/dl IFN-γ pg/ml Alive at hospital discharge
Unknown, EBV+ 744 3.5 3.5 50 229 9.0 No

Cryptococcus, pulmonary TB 710 7.3 4.2 60 150 60 Yes

S. pneumoniae 782 18.7 3.1 800 276 Yes

Unknown 1009 17.3 3.2 <5 173 Left AMA

Unknown 1364 9.6 2.0 2580 120 No

Viral 655 3.0 3.5 45 279 310 Unknown

Unknown 649 3.4 2.7 100 443 1.1 Left AMA

Putative TBM 622 5.8 4.9 352 283 8.5 No

Putative TBM 886 9.1 5.4 310 250 10.4 Yes

Unknown, EBV+ 1404 14.1 17.8 75 20 1.3 Unknown

Unknown 687 0.36 1.1 25 40 140 No

Participants selected for this analysis when DLL1 was >600 pg/ml without confirmed TBM. Clinical diagnosis was made by the treating physicians with information available at the time.

AMA: Against medical advice; CSF: Cerebrospinal fluid; EVB: Epstein–Barr virus; TB: Mycobacterium tuberculosis; TBM: Tuberculosis meningitis; WBC: White blood cell.